Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease
Toshiki Tezuka,Mayu Ishiguro,Daisuke Taniguchi,Ehoto Osogaguchi,Kahori Shiba-Fukushima,Jun Ogata,Ryota Ishii,Aya Ikeda,Yuanzhe Li,Hiroyo Yoshino,Taro Matsui,Kenichi Kaida,Manabu Funayama,Kenya Nishioka,Fumihisa Kumazawa,Tomoyasu Matsubara,Hitoshi Tsuda,Yuko Saito,Shigeo Murayama,Yuzuru Imai,Nobutaka Hattori
DOI: https://doi.org/10.1016/j.nbd.2024.106571
IF: 7.046
2024-06-19
Neurobiology of Disease
Abstract:Leucine-rich repeat kinase 2 ( LRRK2 ) is the most common gene responsible for familial Parkinson's disease (PD). The gene product of LRRK2 contains multiple protein domains, including armadillo repeat, ankyrin repeat, leucine-rich repeat (LRR), Ras-of-complex (ROC), C-terminal of ROC (COR), kinase, and WD40 domains. In this study, we performed genetic screening of LRRK2 in our PD cohort, detecting sixteen LRRK2 rare variants. Among them, we selected seven variants that are likely to be familial and characterized them in terms of LRRK2 protein function, along with clinical information and one pathological analysis. The seven variants were S1120P and N1221K in the LRR domain; I1339M, S1403R, and V1447M in the ROC domain; and I1658F and D1873H in the COR domain. The kinase activity of the LRRK2 variants N1221K, S1403R, V1447M, and I1658F toward Rab10, a well-known phosphorylation substrate, was higher than that of wild-type LRRK2. LRRK2 D1873H showed enhanced self-association activity, whereas LRRK2 S1403R and D1873H showed reduced microtubule-binding activity. Pathological analysis of a patient with the LRRK2 V1447M variant was also performed, which revealed Lewy pathology in the brainstem. No functional alterations in terms of kinase activity, self-association activity, and microtubule-binding activity were detected in LRRK2 S1120P and I1339M variants. However, the patient with PD carrying LRRK2 S1120P variant also had a heterozygous Glucosylceramidase beta 1 ( GBA1 ) L444P variant. In conclusion, we characterized seven LRRK2 variants potentially associated with PD. Five of the seven variants in different LRRK2 domains exhibited altered properties in kinase activity, self-association, and microtubule-binding activity, suggesting that each domain variant may contribute to disease progression in different ways.
neurosciences